Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Index by author

December 15, 2022; Volume 19,Issue 12
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Bai, Rilan

    1. You have access
      Potential new applications of immunotherapy for neuroendocrine neoplasms: immune landscape, current status and future perspectives
      Rilan Bai, Wenqian Li and Jiuwei Cui
      Cancer Biology & Medicine December 2022, 19 (12) 1649-1661; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0489
  2. Bi, Zhao

    1. You have access
      Inconsistent radiotherapy effects between primary tumors and axillary lymph nodes
      Zhao Bi, Pengfei Qiu, Zhaopeng Zhang and Yongsheng Wang
      Cancer Biology & Medicine December 2022, 19 (12) 1617-1621; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0590
  3. Chen, Lin

    1. You have access
      MiR-378a-3p acts as a tumor suppressor in gastric cancer via directly targeting RAB31 and inhibiting the Hedgehog pathway proteins GLI1/2
      Xinxin Xu, Yang Li, Guoxiao Liu, Kai Li, Peng Chen, Yunhe Gao, Wenquan Liang, Hongqing Xi, Xinxin Wang, Bo Wei, Hongtao Li and Lin Chen
      Cancer Biology & Medicine December 2022, 19 (12) 1662-1682; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0337
  4. Chen, Peng

    1. You have access
      MiR-378a-3p acts as a tumor suppressor in gastric cancer via directly targeting RAB31 and inhibiting the Hedgehog pathway proteins GLI1/2
      Xinxin Xu, Yang Li, Guoxiao Liu, Kai Li, Peng Chen, Yunhe Gao, Wenquan Liang, Hongqing Xi, Xinxin Wang, Bo Wei, Hongtao Li and Lin Chen
      Cancer Biology & Medicine December 2022, 19 (12) 1662-1682; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0337
  5. Chen, Song

    1. You have access
      Heterogeneity of neutrophils in cancer: one size does not fit all
      Song Chen, Qingyu Zhang, Lisha Lu, Chunhui Xu, Jiajia Li, Jiali Zha, Fengxia Ma, Hongbo R. Luo and Alan Y. Hsu
      Cancer Biology & Medicine December 2022, 19 (12) 1629-1648; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0426
  6. Cui, Jiuwei

    1. You have access
      Potential new applications of immunotherapy for neuroendocrine neoplasms: immune landscape, current status and future perspectives
      Rilan Bai, Wenqian Li and Jiuwei Cui
      Cancer Biology & Medicine December 2022, 19 (12) 1649-1661; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0489
  7. Gao, Yunhe

    1. You have access
      MiR-378a-3p acts as a tumor suppressor in gastric cancer via directly targeting RAB31 and inhibiting the Hedgehog pathway proteins GLI1/2
      Xinxin Xu, Yang Li, Guoxiao Liu, Kai Li, Peng Chen, Yunhe Gao, Wenquan Liang, Hongqing Xi, Xinxin Wang, Bo Wei, Hongtao Li and Lin Chen
      Cancer Biology & Medicine December 2022, 19 (12) 1662-1682; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0337
  8. Hsu, Alan Y.

    1. You have access
      Heterogeneity of neutrophils in cancer: one size does not fit all
      Song Chen, Qingyu Zhang, Lisha Lu, Chunhui Xu, Jiajia Li, Jiali Zha, Fengxia Ma, Hongbo R. Luo and Alan Y. Hsu
      Cancer Biology & Medicine December 2022, 19 (12) 1629-1648; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0426
  9. Li, Hongtao

    1. You have access
      MiR-378a-3p acts as a tumor suppressor in gastric cancer via directly targeting RAB31 and inhibiting the Hedgehog pathway proteins GLI1/2
      Xinxin Xu, Yang Li, Guoxiao Liu, Kai Li, Peng Chen, Yunhe Gao, Wenquan Liang, Hongqing Xi, Xinxin Wang, Bo Wei, Hongtao Li and Lin Chen
      Cancer Biology & Medicine December 2022, 19 (12) 1662-1682; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0337
  10. Li, Jiajia

    1. You have access
      Heterogeneity of neutrophils in cancer: one size does not fit all
      Song Chen, Qingyu Zhang, Lisha Lu, Chunhui Xu, Jiajia Li, Jiali Zha, Fengxia Ma, Hongbo R. Luo and Alan Y. Hsu
      Cancer Biology & Medicine December 2022, 19 (12) 1629-1648; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0426
« Previous (Pages : 1 2 3 ... 3) Next »
Back to top
PreviousNext

In this issue

Cancer Biology & Medicine: 19 (12)
Cancer Biology & Medicine
Vol. 19, Issue 12
15 Dec 2022
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire